A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...
A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Jozefina Casuscelli discussing the optimal management of de-novo ...
Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...
New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results